TY - JOUR
T1 - The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: A prospective cohort study.
AU - Verdonck-de Leeuw, I.M.
AU - Buffart, L.M.
AU - Heijmans, M.W.
AU - Rietveld, D.H.F.
AU - Doornaert, P.
AU - de Bree, R.
AU - Buter, J.
AU - Aaronson, N.K.
AU - Slotman, B.J.
AU - Leemans, C.R.
AU - Langendijk, J.A.
AU - Heymans, M.W.
PY - 2014/3
Y1 - 2014/3
N2 - Background and purpose To evaluate the course of health-related quality of life (HRQOL) from diagnosis to 2 years follow-up in patients with head and neck cancer (HNSCC) treated with chemoradiation (CRT). Materials and methods 164 patients completed the EORTC QLQ-C30 and QLQ-H&N35 questionnaires 1 week before and 6 weeks and 6, 12, 18, and 24 months after CRT. Patients were compared to a reference group. A linear mixed-model analysis was used to assess changes in HRQOL over time, and whether this was associated with age, gender, comorbidity, and tumor sublocation. Results Significant differences for the majority of HRQOL scales were observed between patient and reference group at baseline, and follow-up. The course of HRQOL was different for survivors compared to non-survivors. In survivors, improvement over time was observed (in global quality of life, physical, role, and social function, fatigue, pain, swallowing, speech, social eating, and social contacts), while in non-survivors the pattern over time was either no changes in HRQOL or a deterioration (in physical function, social eating and contacts). In both survivors and non-survivors, emotional functioning improved after treatment, but deteriorated in the longer term. Patients with comorbidity reported worse physical function, and patients with oral/oropharyngeal cancer (compared to hypopharyngeal/ laryngeal cancer) reported more oral pain and sexual problems, but fewer speech problems. Conclusions The course of HRQOL of HNSCC patients during the first 2 years after CRT is different for survivors compared to non-survivors and is associated with comorbidity and tumor subsite. © 2013 Elsevier Ireland Ltd. All rights reserved.
AB - Background and purpose To evaluate the course of health-related quality of life (HRQOL) from diagnosis to 2 years follow-up in patients with head and neck cancer (HNSCC) treated with chemoradiation (CRT). Materials and methods 164 patients completed the EORTC QLQ-C30 and QLQ-H&N35 questionnaires 1 week before and 6 weeks and 6, 12, 18, and 24 months after CRT. Patients were compared to a reference group. A linear mixed-model analysis was used to assess changes in HRQOL over time, and whether this was associated with age, gender, comorbidity, and tumor sublocation. Results Significant differences for the majority of HRQOL scales were observed between patient and reference group at baseline, and follow-up. The course of HRQOL was different for survivors compared to non-survivors. In survivors, improvement over time was observed (in global quality of life, physical, role, and social function, fatigue, pain, swallowing, speech, social eating, and social contacts), while in non-survivors the pattern over time was either no changes in HRQOL or a deterioration (in physical function, social eating and contacts). In both survivors and non-survivors, emotional functioning improved after treatment, but deteriorated in the longer term. Patients with comorbidity reported worse physical function, and patients with oral/oropharyngeal cancer (compared to hypopharyngeal/ laryngeal cancer) reported more oral pain and sexual problems, but fewer speech problems. Conclusions The course of HRQOL of HNSCC patients during the first 2 years after CRT is different for survivors compared to non-survivors and is associated with comorbidity and tumor subsite. © 2013 Elsevier Ireland Ltd. All rights reserved.
U2 - https://doi.org/10.1016/j.radonc.2014.01.002
DO - https://doi.org/10.1016/j.radonc.2014.01.002
M3 - Article
C2 - 24582144
SN - 0167-8140
VL - 110
SP - 422
EP - 428
JO - Radiotherapy and oncology
JF - Radiotherapy and oncology
IS - 3
ER -
